Modeling the Cost-Effectiveness of Successive Preventive Oral Medication Trials in Chronic Migraine

被引:0
|
作者
Ney, J. [1 ]
Guirguis, A. [1 ]
Dao, V [2 ]
Sico, J. [1 ]
机构
[1] VA Connecticut Hlth Care Syst, West Haven, CT USA
[2] Minneapolis VA Med Ctr, Minneapolis, MN USA
来源
HEADACHE | 2023年 / 63卷
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P-213
引用
收藏
页码:195 / 196
页数:2
相关论文
共 50 条
  • [1] 10-YEAR COST-EFFECTIVENESS ANALYSES OF FREMANEZUMAB AS PREVENTIVE TREATMENT IN CHRONIC AND EPISODIC MIGRAINE
    Smolen, L.
    Gandhi, S. K.
    Klein, T.
    Iyer, R.
    Thompson, S.
    Cohen, J. M.
    Lipton, R. B.
    VALUE IN HEALTH, 2019, 22 : S273 - S273
  • [2] 10-Year Cost-Effectiveness Analyses of Fremanezumab as Preventive Treatment in Chronic and Episodic Migraine
    Smolen, L.
    Gandhi, S. K.
    Klein, T.
    Iyer, R.
    Thompson, S.
    Cohen, J. M.
    Lipton, R. B.
    HEADACHE, 2019, 59 : 69 - 70
  • [3] Cost-effectiveness analysis of oral N-acetylcysteine as a preventive treatment in chronic bronchitis
    Grandjean, EM
    Berthet, P
    Ruffmann, R
    Leuenberger, P
    PHARMACOLOGICAL RESEARCH, 2000, 42 (01) : 39 - 50
  • [4] Cost-Effectiveness of Initial Prophylactic Treatment of Chronic Migraine: Oral Medications versus OnabotulinumtoxinA
    Kelley, Kristin
    Schoenbrunner, Anna
    Murphy, James
    NEUROLOGY, 2016, 86
  • [5] COST-EFFECTIVENESS OF ONABOTULINUMTOXIN-A FOR THE PROPHYLAXIS OF CHRONIC MIGRAINE
    Ruggeri, M.
    Carletto, A.
    Marchetti, M.
    VALUE IN HEALTH, 2012, 15 (07) : A553 - A553
  • [6] COST-EFFECTIVENESS ANALYSIS OF EREMUMAB (AIMOVIG®) FOR THE PREVENTIVE TREATMENT OF MIGRAINE IN SPAIN
    Poveda, J. L.
    Irimia, P.
    Sanchez, S.
    Crespo, C.
    Martinez, M.
    Pozo-Rosich, P.
    VALUE IN HEALTH, 2022, 25 (12) : S98 - S98
  • [7] Cost-effectiveness in preventive cardiology
    Weintraub W.S.
    Current Treatment Options in Cardiovascular Medicine, 2004, 6 (4) : 279 - 290
  • [8] Cost-effectiveness of oral treatments for chronic hepatitis B
    Dusheiko, Geoffrey M.
    JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 623 - 625
  • [9] Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B
    Buti, Maria
    Brosa, Max
    Casado, Miguel A.
    Rueda, Magdalena
    Esteban, Rafael
    JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 640 - 646
  • [10] COST-EFFECTIVENESS OF ORAL TRIPTANS FOR ACUTE MIGRAINE: MIXED TREATMENT COMPARISON
    Asseburg, Christian
    Peura, Piia
    Oksanen, Tuija
    Turunen, Juha
    Purmonen, Timo
    Martikainen, Janne
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (04) : 382 - 389